Malignant breast tumors after radiotherapy for a first cancer during childhood

被引:100
作者
Guibout, C
Adjadj, E
Rubino, C
Shamsaldin, A
Grimaud, E
Hawkins, M
Mathieu, MC
Oberlin, O
Zucker, JM
Panis, X
Lagrange, JL
Daly-Schveitzer, N
Chavaudra, J
de Vathaire, F
机构
[1] Inst Gustave Roussy, INSERM, Unite 605, Canc Epidemiol Res Unit, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Natl Inst Hlth & Med Res, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Phys, F-94805 Villejuif, France
[4] Inst Gustave Roussy, Dept Paediat, F-94805 Villejuif, France
[5] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
[6] Inst Curie, Dept Pediat, Paris, France
[7] Inst Jean Godinoi, Dept Radiotherapy, F-51056 Reims, France
[8] Ctr Antoine Lacassagne, Dept Radiotherapy, F-06054 Nice, France
[9] Ctr Claudius Regaud, Dept Radiotherapy, Toulouse, France
[10] Radcliffe Infirm, Childhood Canc Res Grp, Oxford OX2 6HE, England
关键词
D O I
10.1200/JCO.2005.06.225
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To assess the specific role of treatment and type of first cancer (FC) in the risk of long-term subsequent breast cancer (BC) among childhood cancer survivors. Patients and Methods In a cohort of 1,814 3-year female survivors treated between 1946 and 1986 in eight French and English centers, data on chemotherapy and radiotherapy were collected. Individual estimation of radiation dose to each breast was performed for the 1,258 patients treated by external radiotherapy; mean dose to breast was 5.06 Gy (range, 0.0 to 88.0 Gy) delivered in 20 fractions (mean). Results Mean follow-up was 16 years; 16 patients developed a clinical BC, 13 after radiotherapy. The cumulative incidence of BC was 2.8% (95% CI, 1.0% to 4.5%) 30 years after the FC and 5.1% (95% CI, 2.1% to 8.2%) at the age of 40 years. The annual excess incidence increased as age increased, whereas the standardized incidence ratio decreased. On average, each Gray unit received by any breast increased the excess relative risk of BC by 0.13 (< 0.0 to 0.75). After stratification on castration and attained age, and adjusting for radiation dose, FC type, and chemotherapy, a higher risk of a subsequent BC was associated with Hodgkin's disease (relative risk, 7.0; 95% CI, 1.4 to 30.9). Conclusion The reported high risk of BC after childhood Hodgkin's disease treatment seems to be due not only to a higher radiation dose to the breasts, but also to a specific susceptibility.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 52 条
[41]  
2-K
[42]  
MENEGOZ F, 1998, CANC FRANCE INCIDEND
[43]   Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence [J].
Metayer, C ;
Lynch, CF ;
Clarke, EA ;
Glimelius, B ;
Storm, H ;
Pukkala, E ;
Joensuu, T ;
van Leeuwen, FE ;
van't Veer, MB ;
Curtis, RE ;
Holowaty, EJ ;
Andersson, M ;
Wiklund, T ;
Gospodarowicz, M ;
Travis, LB .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) :2435-2443
[44]   INCREASED RISK OF BREAST-CANCER AFTER LOW-DOSE IRRADIATION [J].
MODAN, B ;
ALFANDARY, E ;
CHETRIT, A ;
KATZ, L .
LANCET, 1989, 1 (8639) :629-631
[45]  
Nations United, 1994, ION RAD SOURC BIOL E
[46]   Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study [J].
Neglia, JP ;
Friedman, DL ;
Yasui, Y ;
Mertens, AC ;
Hammond, S ;
Stovall, M ;
Donaldson, SS ;
Meadows, AT ;
Robison, LL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (08) :618-629
[47]   2ND MALIGNANT NEOPLASMS AFTER CANCER IN CHILDHOOD OR ADOLESCENCE [J].
OLSEN, JH ;
GARWICZ, S ;
HERTZ, H ;
JONMUNDSSON, G ;
LANGMARK, F ;
LANNING, M ;
LIE, SO ;
MOE, PJ ;
MOLLER, T ;
SANKILA, R ;
TULINIUS, H .
BRITISH MEDICAL JOURNAL, 1993, 307 (6911) :1030-1036
[48]   Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries [J].
Sankila, R ;
Garwicz, S ;
Olsen, JH ;
Dollner, H ;
Hertz, H ;
Kreuger, A ;
Langmark, F ;
Lanning, M ;
Moller, T .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1442-1446
[49]   Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood [J].
Shamsaldin, A ;
Grimaud, E ;
Hardiman, C ;
Diallo, I ;
de-Vathaire, F ;
Chavaudra, J .
RADIOTHERAPY AND ONCOLOGY, 1998, 49 (01) :85-90
[50]   Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment [J].
Swerdlow, AJ ;
Barber, JA ;
Hudson, GV ;
Cunningham, D ;
Gupta, RK ;
Hancock, BW ;
Horwich, A ;
Lister, TA ;
Linch, DC .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :498-509